About The Event
DIA 2017 is fast approaching and we couldn't be more excited to exhibit our solutions. If you are planning on attending, please "connect and recharge" with us at Booth #1107.
When:
June 18-22, 2017
Where:
McCormick Place
Chicago, IL
www.diaglobal.org
Booth #1107
Tuesday, June 20 | 2:00 pm - 3:00 pm
Comparative Effectiveness: State of the Art and Stakeholder Perspectives
Mind the "Efficacy-Effectiveness" Gap: Will Changes in Regulations on Real-World Research Revolutionize Health Technology Assessment?
Session in Track 10: Value and Access
David Thompson
Senior Vice President,
Real-World Evidence & Insights,
inVentiv Health
David Thompson, PhD is Senior Vice President, Real World Evidence & Insights, for InVentiv Health. Dr. Thompson is a health economist with 25+ years of experience in the real-world research arena. Prior to joining inVentiv Health, he held leadership positions at Quintiles (2012-2016), i3 Innovus/OptumInsight (2000-2012) and PAI (1988-2000). He has also served as Editor-in-Chief of ISPOR’s publication, Value & Outcomes Spotlight, since 2007.
inVentiv Health by the Numbers
> 15,000 inVentiv Health Experts
helping global clients realize their goals
in clinical development and commercialization.
> 90 Countries  
in which inVentiv Health has the ability to support clients.
550 Global Pharmaceutical Companies
have turned to inVentiv Health for expertise, skills and insight.
inVentiv Health is one of the nation’s largest providers of direct-to-patient communcations with real-time access to 9 years of data that includes:
30,000 Pharmacies
194M+ Health Consumers
285,000 Physicians
2.2 Billion Annual Prescriptions
60% of all retail prescriptions
across 35 chains
In the past 5 years, inVentiv Health
has helped to develop or commercialize:
Approved by the FDA
82%
Novel New Drugs
82%
Novel New Oncology Drugs
93%
Novel New Central Nervous System Drugs
Approved by the EMA
70%
Products Granted Marketing Authorization
81%
Oncology Drugs
67%
Central Nervous System Drugs